5252
T. Kamino et al. / Tetrahedron Letters 42 (2001) 5249–5252
9. (i) NaBH4, THF–H2O (3:1); (ii) LiOOH, THF–H2O (3:1),
3. Chong, R. R.; Gray, W.; King, R. R.; Whalley, W. B. J.
63% in two steps; (iii) TBSCl, i-Pr2NEt, DMAP, DMF,
0°C, 3.5 h, 75%; (iv) Li, NH3, THF, −78°C, 2 h, 64%; (v)
2,2-dimethoxypropane, CSA, CH2Cl2, rt, 2 h, 82%.
10. (i) NaBH4, THF–H2O (3:1); (ii) LiOOH, THF–H2O (3:1),
63% in two steps; (iii) BnCl, NaH, TBAI, THF, 91%; (iv)
OsO4, NMO, acetone–H2O (5:1), 99%; (v) Pb(OAc)4,
benzene; (vi) NaBH4, MeOH, 80% in two steps; (vii) H2,
Pd–C, MeOH, quant.
Chem. Soc. (C) 1971, 3571–3575.
4. Hosokawa, S.; Sekiguchi, K.; Enemoto, M.; Kobayashi,
S. Tetrahedron Lett. 2000, 41, 6429–6433.
5. Evans, D. A.; Bartroli, J.; Shih, T. L. J. Am. Chem. Soc.
1981, 103, 2127–2129.
6. Nerz-Stormes, M.; Thornton, E. Tetrahedron Lett. 1986,
27, 897–900.
7. General procedure: To a solution of LDA (prepared from
DIPA (27.1 ml, 206 mmol), and n-BuLi (1.6 M in hexane,
118 ml, 189 mmol) at −15°C for 15 min) was added a
solution of 5 (50.0 mg, 172 mmol) at −78°C. After stirring
for 30 min at −78°C, TiCl(Oi-Pr)3 (1.0 M in hexane, 568
ml, 568 mmol) was added and the resulting mixture was
stirred for 1 h at −40°C. After cooling to −78°C, croton-
aldehyde (15.2 ml, 189 mmol) was added to the mixture
which was additionally stirred at −40°C for 2 h. The
reaction mixture was quenched with sat. NH4Cl and
stirred with Celite for 1 h at rt. Filtration, extraction with
AcOEt, washing the organic layer with brine followed by
drying with Na2SO4 and evaporation gave a crude oil,
which was purified by preparative TLC (hexane:AcOEt=
2:1) to yield 6a (39.1 mg, 63%). 6a: Rf=0.50 (hex-
11. (i) BnOLi, BnOH, THF, −78 to 0°C, 32% for 6a, 34% for
6b; (ii) MnO2, CH2Cl2, rt, 46% for 6a, 59% for 6b. 9
(from 6a) [h]2D5=+7.02 (c 0.340, CHCl3); 9 (from 6b)
[h]2D5=+7.81 (c 0.573, CHCl3).
12. 15: Rf=0.39 (hexane:AcOEt=5:1); [h]2D2=+26.8 (c 0.774,
1
CHCl3); H NMR (400 MHz, CDCl3): l (ppm) 0.11 (3H,
s), 0.24 (3H, s) 0.91–0.93 (15H, m), 1.57 (3H, s), 1.74 (3H,
dd, J=6.3, 1.2 Hz), 2.29–2.37 (1H, m), 2.52 (1H, bs), 4.23
(1H, dd, J=8.4, 3.4 Hz), 4.32 (1H, t, J=8.7 Hz), 4.57
(1H, dt, J=8.7, 3.4 Hz), 4.97 (1H, dd, J=11.1, 7.7 Hz),
5.53 (1H, ddq, J=15.3, 7.7, 1.2), 5.80 (1H, dq, J=15.3,
6.4 Hz). 13C NMR (100 MHz, CDCl3): l (ppm) −2.5,
14.5, 17.9, 17.9, 18.8, 21.3, 26.1, 28.1, 60.4, 63.3, 75.1,
83.8, 128.6, 130.1, 152.9, 174.6; IR (neat) 3555, 2956,
2856, 1780, 1702, 1471, 1388, 1252, 1190, 1130, 996, 837,
758 cm−1; HR-EIMS: calcd for C18H32NO5Si ([M−Me]+)
370.2050, found 370.2032.
1
ane:AcOEt=2:1); [h]D23=−35.3 (c 4.94, CHCl3); H NMR
(400 MHz, CDCl3): l (ppm) 0.86 (3H, d, J=6.59 Hz),
1.03 (3H, d, J=6.6 Hz), 1.45 (3H, s), 1.77 (3H, d, J=6.3
Hz), 2.38–2.47 (1H, m), 2.69 (1H, bs), 3.73 (1H, dd,
J=11.6, 9.3 Hz), 4.06 (1H, dd, J=11.5, 8.5 Hz), 4.41
(1H, bs), 4.49 (1H, d, J=10.0 Hz), 4.61 (1H, d, J=10.9
Hz), 4.88 (1H, d, J=7.8 Hz), 5.45 (1H, dd, J=14.8, 7.8
Hz), 6.01 (1H, dq, J=14.8, 6.3 Hz), 7.26–7.39 (5H, m);
13C NMR (100 MHz, CDCl3): l (ppm) 15.7, 18.0, 19.9,
20.1, 26.0, 62.0, 75.5, 81.7, 121.9, 127.3, 127.8, 135.8,
137.1, 170.5; IR (neat) 3491, 2968, 2455, 1755, 1697,
13. (i) TESCl, DMAP, imidazole, DMF, rt, overnight; (ii)
BnSLi, BnSH, THF, 0°C, 1.5 h; (iii) TBAF, THF, 0°C, 1
h, 70% in three steps; (iv) 2,2-dimethoxypropane, CSA,
CH2Cl2, rt, overnight, 92%; (v) NaBH4, i-PrOH, rt,
overnight, 55%.
14. Leal, W. S.; Shi, X.; Nakamura, K.; Ono, M.; Meinwald,
J. Proc. Natl. Acad. Sci. USA 1995, 92, 1038–1042.
15. (i) BOMCl, DMAP, i-Pr2NEt, CH2Cl2, rt, 2 days, 89%;
(ii) DIBAL, CH2Cl2, rt, 2 h; (iii) TBAF, THF, 0°C, 2 h,
69% in two steps; (iv) H2, Pd–C, AcOEt, rt, 1.5 h; (v)
Pb(OAc)4, benzene, 1 h, 88% in two steps; (vi) H2,
Pd(OH)2, MeOH, 5 h, 53%.
1454, 1372, 1213, 1124, 1027, 760 cm−1
8. Fontana, A.; Messina, R.; Spinella, A.; Cimino, G. Tet-
rahedron Lett. 2000, 41, 7559–7562.
.
.